Physiopathology and Regulation of Factor XIII

Factor XIII is a plasma transglutaminase. Transglutaminases are at least 8 enzymes which cross-link a number of proteins. This type of reaction not only enhances the original functions of substrate proteins, but also adds new functions to them. Factor XIII in plasma is a tetramer (A2B2), and the A subunit contains the active site. Although transglutaminases are homologous, the nucleotide sequences in their 5'-flanking region differ significantly. Accordingly, transcription factors play a major role in the cell type-specific expression of each transglutaminase. A variety of missense and nonsense mutations, and deletions/insertions with or without out-of-frame shift/premature termination and splicing abnormalities have been identified in the genes for A and B subunits in factor XIII deficiency. In some cases, the mRNA level of the A or B subunit was severely reduced. Molecular and cellular bases have also been explored by expression experiments and by molecular modeling. In most cases, impaired folding and/or conformational change of the mutant A or B subunit leads to both intra- and extra-cellular instability, which is responsible for factor XIII deficiency.

[1]  M. Yamakawa,et al.  Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. , 2001, Blood.

[2]  C. Sadasivan,et al.  Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex. , 2000, The Journal of biological chemistry.

[3]  J. Weisel,et al.  The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. , 2000, Blood.

[4]  M. Maurer,et al.  Examining Thrombin Hydrolysis of the Factor XIII Activation Peptide Segment Leads to a Proposal for Explaining the Cardioprotective Effects Observed with the Factor XIII V34L Mutation* , 2000, The Journal of Biological Chemistry.

[5]  T. Terao,et al.  Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. , 2000, Placenta.

[6]  F. Cambien,et al.  The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. , 2000, Blood.

[7]  A. Ichinose,et al.  Molecular and genetic mechanisms of factor XIII A subunit deficiency. , 2000, Seminars in thrombosis and hemostasis.

[8]  I. Komáromi,et al.  Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. , 2000, Blood.

[9]  R. Anwar,et al.  FACTOR XIII DEFICIENCY , 1999, British journal of haematology.

[10]  R. Stockbrügger,et al.  Differential Behavior of Coagulation Factor XIII in Patients with Inflammatory Bowel Disease and in Patients with Giant Cell Arteritis , 1999, Pathophysiology of Haemostasis and Thrombosis.

[11]  P. Grant,et al.  Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Yamamoto,et al.  Transcriptional Regulation of Cell Type-specific Expression of the TATA-less A Subunit Gene for Human Coagulation Factor XIII* , 1999, The Journal of Biological Chemistry.

[13]  G. Chelvanayagam,et al.  Identification and characterization of two missense mutations causing factor XIIIA deficiency , 1999, British journal of haematology.

[14]  P. Reitsma,et al.  A Genetic Propensity to High Factor VII Is not Associated with the Risk of Myocardial Infarction in Men , 1998 .

[15]  G. Chelvanayagam,et al.  A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit: its effects on protein structure and function. , 1998, Blood.

[16]  J. Takamatsu,et al.  Arg260‐Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics , 1998, British journal of haematology.

[17]  F. Rodeghiero,et al.  Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. , 1998, Blood.

[18]  T. Saito,et al.  Novel Deletion and Insertion Mutations Cause Splicing Defects, Leading to Severe Reduction in mRNA Levels of the A Subunit in Severe Factor XIII Deficiency , 1998, Thrombosis and Haemostasis.

[19]  M. Weiss,et al.  Two non‐proline cis peptide bonds may be important for factor XIII function , 1998, FEBS letters.

[20]  W. Jefferies,et al.  Possible Roles of Transglutaminases in Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[21]  A. Carter,et al.  Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.

[22]  A. Markham,et al.  Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family. , 1998, Blood.

[23]  M. Suzuki,et al.  Activation of the human transglutaminase 1 promoter in transgenic mice: terminal differentiation-specific expression of the TGM1-lacZ transgene in keratinized stratified squamous epithelia. , 1997, Human molecular genetics.

[24]  R. Gonzales,et al.  Organization and structure of the human tissue transglutaminase gene. , 1997, Biochimica et biophysica acta.

[25]  A. Palotie,et al.  Molecular Mechanisms of Mutations in Factor XIII A-subunit Deficiency: In vitro Expression in COS-cells Demonstrates Intracellular Degradation of the Mutant Proteins , 1997, Thrombosis and Haemostasis.

[26]  L. Peltonen,et al.  Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. , 1997, Blood.

[27]  D. Foster,et al.  Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. , 1996, Journal of biochemistry.

[28]  A. Tosetto,et al.  Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. , 1996, Blood.

[29]  P. Steinert,et al.  The Proximal Promoter of the Human Transglutaminase 3 Gene , 1996, The Journal of Biological Chemistry.

[30]  H. Nishiura,et al.  Monocyte Chemotactic Factor in Rheumatoid Arthritis Synovial Tissue , 1996, The Journal of Biological Chemistry.

[31]  A. Ichinose,et al.  The Normal and Abnormal Genes of the a and b Subunits in Coagulation Factor XIII , 1996, Seminars in thrombosis and hemostasis.

[32]  R. Rice,et al.  Keratinocyte Transglutaminase Promoter Analysis: , 1995, The Journal of Biological Chemistry.

[33]  G. Melino,et al.  Biochemical, Structural, and Transglutaminase Substrate Properties Of Human Loricrin, the Major Epidermal Cornified Cell Envelope Protein (*) , 1995, The Journal of Biological Chemistry.

[34]  A. Stewart,et al.  Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function , 1995, British journal of haematology.

[35]  G. Johnson,et al.  Transglutaminase Cross‐Linking of the τ Protein , 1995 .

[36]  L. Pedersen,et al.  Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. , 1995, Thrombosis research.

[37]  A. Baldini,et al.  Localization of the human prostate transglutaminase (type IV) gene (TGM4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization. , 1995, Genomics.

[38]  R. Baker,et al.  Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast. , 1995, Blood.

[39]  P. Davies,et al.  Isolation and Characterization of the Human Tissue Transglutaminase Gene Promoter (*) , 1995, The Journal of Biological Chemistry.

[40]  A. Ichinose,et al.  Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain. , 1995, The Journal of clinical investigation.

[41]  I. Kurochkin,et al.  Domain structure, stability and domain-domain interactions in recombinant factor XIII. , 1995, Journal of molecular biology.

[42]  P. Steinert,et al.  Structure and organization of the human transglutaminase 3 gene: evolutionary relationship to the transglutaminase family. , 1994, The Journal of investigative dermatology.

[43]  L. Pedersen,et al.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Rosen,et al.  Role of scatter factor in the pathogenesis of AIDS-related Kaposi sarcoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Baldini,et al.  The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization. , 1994, Genomics.

[46]  A. Ichinose,et al.  Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. , 1993, Blood.

[47]  K. Kuma,et al.  Limulus hemocyte transglutaminase. cDNA cloning, amino acid sequence, and tissue localization. , 1993, The Journal of biological chemistry.

[48]  A. Ichinose,et al.  Molecular approach to structure-function relationship of human coagulation factor XIII. , 1993, Methods in enzymology.

[49]  J. Inazawa,et al.  Structure of the gene for human transglutaminase 1. , 1992, The Journal of biological chemistry.

[50]  O. Mcbride,et al.  Structure and organization of the human transglutaminase 1 gene. , 1992, The Journal of biological chemistry.

[51]  B. E. Stewart,et al.  Genomic structure of keratinocyte transglutaminase. Recruitment of new exon for modified function. , 1992, The Journal of biological chemistry.

[52]  Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting. , 1992, Biochimica et biophysica acta.

[53]  C. M. Cohen,et al.  Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Tosetto,et al.  Clinical pharmacokinetics of a placenta‐derived factor XIII concentrate in type I and type II factor XIII deficiency , 1991, American journal of hematology.

[55]  E. Davie,et al.  Nucleotide sequence of the gene for the b subunit of human factor XIII. , 1990, Biochemistry.

[56]  E. Davie,et al.  Structure of transglutaminases. , 1990, The Journal of biological chemistry.

[57]  B. Dahlbäck,et al.  Human genes for the alpha and beta chains of complement C4b-binding protein are closely linked in a head-to-tail arrangement. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[58]  K. Okafuji,et al.  A familial factor XIII subunit B deficiency , 1990, British journal of haematology.

[59]  D. Speicher,et al.  Complete amino acid sequence and homologies of human erythrocyte membrane protein band 4.2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Griffiths,et al.  Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas. , 1989, Science.

[61]  H. Erickson,et al.  Electron microscopy and hydrodynamic properties of factor XIII subunits. , 1989, The Journal of biological chemistry.

[62]  E. Davie,et al.  Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Sasaki,et al.  Amino acid sequence of guinea pig liver transglutaminase from its cDNA sequence. , 1988, Biochemistry.

[64]  G. Webb,et al.  Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24----p25. , 1988, Cytogenetics and cell genetics.

[65]  Y. Kan,et al.  Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis. , 1987, The Journal of clinical investigation.

[66]  A. Wölpl,et al.  COAGULATION FACTOR XIII A AND B SUBUNITS IN BONE MARROW AND LIVER TRANSPLANTATION , 1987, Transplantation.

[67]  A. Girolami,et al.  A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency. , 1987, Haematologia.

[68]  K. Fujikawa,et al.  Amino acid sequence of the a subunit of human factor XIII. , 1986, Biochemistry.

[69]  Y. Takahashi,et al.  Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[70]  E. Amann,et al.  Characterization of cDNA coding for human factor XIIIa. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Fujikawa,et al.  Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. , 1986, Biochemistry.

[72]  J. Nagy,et al.  Biosynthesis of factor XIII B subunit by human hepatoma cell lines. , 1986, Blood.

[73]  L. Lorand,et al.  Human factor XIII: fibrin-stabilizing factor. , 1980, Progress in hemostasis and thrombosis.

[74]  F. Fabris,et al.  Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups. , 1978, Folia haematologica.